Stockscreener 앱 받기
7.4416
0.13%
0.0284
전일 마감가:
$7.47
열려 있는:
$7.42
하루 거래량:
23,053
Relative Volume:
0.07
시가총액:
$196.15M
수익:
$56.65M
순이익/손실:
$-53.31M
주가수익비율:
-3.6403
EPS:
-2.0442
순현금흐름:
$-40.75M
1주 성능:
-11.90%
1개월 성능:
+23.03%
6개월 성능:
-9.22%
1년 성능:
-35.29%
1일 변동 폭
$7.325
$7.55
1주일 범위
$7.325
$8.49
52주 변동 폭
$4.2993
$13.34
Cvrx Inc Stock (CVRX) Company Profile
명칭
Cvrx Inc
전화
(763) 416-2850
주소
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
Compare CVRX vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
7.455 | 196.55M | 56.65M | -53.31M | -40.75M | -2.0442 |
|
ABT
Abbott Laboratories
|
110.17 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
343.04 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
88.94 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
68.88 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
84.60 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-09 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-01-14 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-09-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-07-11 | 재확인 | Lake Street | Buy |
| 2024-05-01 | 재개 | Craig Hallum | Buy |
| 2024-05-01 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-05-01 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | 개시 | Lake Street | Buy |
| 2022-07-18 | 개시 | Craig Hallum | Buy |
| 2021-07-26 | 개시 | Canaccord Genuity | Buy |
| 2021-07-26 | 개시 | Piper Sandler | Overweight |
| 2021-07-26 | 개시 | William Blair | Outperform |
모두보기
Cvrx Inc 주식(CVRX)의 최신 뉴스
Energy Moves: Why is CVRx Inc stock going downMarket Sentiment Review & Smart Allocation Stock Reports - baoquankhu1.vn
CVRx shares rise on CMS inclusion for Barostim implant procedure - MSN
Quarterly Earnings: Is CVRx Inc. stock affected by interest rate hikesTrade Risk Summary & High Return Stock Watch Alerts - Naître et grandir
CVRx, Inc. (NASDAQ:CVRX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
How Cvrx Inc. (CVRX) Affects Rotational Strategy Timing - Stock Traders Daily
Risk Check: Whats the beta of CVRx Inc stock2025 Macro Impact & Weekly High Return Stock Forecasts - baoquankhu1.vn
Barostim device transforms life after severe heart failure, CVRx asserts - Traders Union
Trend Recap: Why is CVRx Inc stock going downPortfolio Return Summary & Safe Capital Growth Trade Ideas - baoquankhu1.vn
CVRx to present late-breaking THT2026 data in clinical webinar - Traders Union
CVRx Introduces New Performance-Based Executive Stock Unit Plan - The Globe and Mail
CVRx (CVRX) lists Chief HR Officer Gregory Morrison as insider on Form 3 - Stock Titan
CVRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
CVRx approves performance stock units tied to 2026-2027 revenue goals - Investing.com Nigeria
CVRx (NASDAQ: CVRX) CFO gets major option, RSU grants and tax sale - Stock Titan
CVRx (CVRX) CEO Kevin Hykes gets major equity grants, sells shares for taxes - Stock Titan
CVRx (NASDAQ: CVRX) officer receives major equity grants, sells shares to cover taxes - Stock Titan
CVRx (NASDAQ: CVRX) CRO gets new stock awards, sells shares for taxes - Stock Titan
COO of CVRx (NASDAQ: CVRX) receives 23,000 options and 15,000 shares - Stock Titan
CVRx (NASDAQ: CVRX) grants revenue-linked PSUs to executives - Stock Titan
CVRX,INVA Dividends - Finviz
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc.CVRX - FinancialContent
SGP,CVRX Earnings - Finviz
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
CVRx opens THT2026 with new scientific data on Barostim outcomes - Traders Union
Heart failure device Barostim tested in 400 patients, data due at THT 2026 - Stock Titan
SGP,CVRX Short Interest - Finviz
CVRX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
CVRx partners with Orlando Health South Lake Hospital for first Barostim implant - Traders Union
CVRx unveils new Barostim research at THT2026 satellite program - Traders Union
IMA,CVRX Latest SEC Filings - Finviz
Smart Money: Should you buy the dip on CVRx IncJuly 2025 Momentum & Low Volatility Stock Suggestions - baoquankhu1.vn
CVRx celebrates milestone with 101st Barostim implant - Traders Union
CVRXCvrx, Inc. Latest Stock News & Market Updates - Stock Titan
Market Catalysts: What is the earnings history of CVRx IncWeekly Market Report & Low Risk Profit Maximizing Plans - baoquankhu1.vn
(CVRX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
$CVRX stock is up 9% today. Here's what we see in our data. - Quiver Quantitative
Monday 2/23 Insider Buying Report: MPLT, CVRX - Nasdaq
Craig-Hallum Maintains CVRx Inc(CVRX.US) With Buy Rating - 富途牛牛
CVRx (NASDAQ:CVRX) Director Buys $297,648.00 in Stock - MarketBeat
CVRx director Jain Mudit K. buys $297k in shares By Investing.com - Investing.com India
CVRx director Jain Mudit K. buys $297k in shares - Investing.com Australia
Insider Purchase: Director at $CVRX Buys 46,800 Shares - Quiver Quantitative
CVRx : Statement of Changes in Beneficial Ownership (Form 4) - marketscreener.com
Director-linked Treo Ventures buys 46,800 CVRx (CVRX) shares - Stock Titan
Bank Watch: Is CVRX stock heavily shorted2025 Macro Impact & Weekly Return Optimization Plans - baoquankhu1.vn
Earnings call transcript: CVRx Q4 2025 sees stock surge despite earnings miss - Investing.com Nigeria
CVRx hosts Advanced Practice Providers Summit in Nashville - Traders Union
Landmark Heart Failure Trial Begins - Medical Product Outsourcing
Securities Fraud Investigation Into CVRx, Inc. (CVRX) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz - The AI Journal
CVRx, Inc. (CVRX) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - marketscreener.com
Can CVRx Inc keep up with sector leadersJuly 2025 Closing Moves & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Cvrx Inc (CVRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.61%
1.47%
자본화:
|
볼륨(24시간):